These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34509920)

  • 1. Generation of induced pluripotent stem cell line (ZZUi030-A) from a patient with spastic paraplegia type 7.
    Zhang Q; Wang Z; Sun H; Chen N; Xu X; Yang J; Gao Y; Wang Y; Xu Y
    Stem Cell Res; 2021 Oct; 56():102525. PubMed ID: 34509920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.
    Raina K; Joshi G; Modak K; Premkumar C; Priyanka S; Rajesh P; Velayudhan SR; Thummer RP
    Stem Cell Res; 2023 Sep; 71():103159. PubMed ID: 37392703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
    Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5).
    Höflinger P; Theurer Y; Schüle R; Schöls L; Hauser S
    Stem Cell Res; 2016 Sep; 17(2):422-425. PubMed ID: 27879216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an integration-free induced pluripotent stem cell line, FJMUi001-A, from a hereditary spastic paraplegia patient carrying compound heterozygous p.P498L and p.R618W mutations in CAPN1 (SPG76).
    Lu YQ; Dong EL; Yang WQ; Lai LL; Lin XH; Ma LX; Chen WJ; Wang N; Lin X
    Stem Cell Res; 2019 Jan; 34():101354. PubMed ID: 30611022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of induced pluripotent stem cell line (RCMGi012-A) from fibroblasts of patient with mucopolysaccharidosis type VI.
    Kondrateva E; Grigorieva O; Panchuk I; Bychkov I; Zakharova E; Tabakov V; Pozhitnova V; Voronina E; Shchagina O; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2023 Dec; 73():103259. PubMed ID: 38006675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of SPAST mutant induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia (HSP) patient.
    Hauser S; Erzler M; Theurer Y; Schuster S; Schüle R; Schöls L
    Stem Cell Res; 2016 Nov; 17(3):485-488. PubMed ID: 27789400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cell line (ZZUi0026-A) from a patient with spinocerebellar ataxia type 3.
    Fang J; Wang Y; Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Xu Y; Zhang X; Kan Q
    Stem Cell Res; 2021 May; 53():102205. PubMed ID: 34087977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cell line (ZZUi0014-A) from a patient with spinocerebellar ataxia type 3.
    Wang Y; Sun H; Wang Z; Yue Y; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2019 Dec; 41():101564. PubMed ID: 31639609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cell line (ZZUi0018-A ) from a patient with spinocerebellar ataxia type 6.
    Yang T; Qin J; Zhang Q; Sun H; Wang Z; Yang J; Liu H; Zhang C; Zhang S; Zhang J; Wang Y; Xu Y
    Stem Cell Res; 2020 Apr; 44():101777. PubMed ID: 32229428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human induced pluripotent stem cell line (SDUBMSi001-A) from a hereditary spastic paraplegia patient carrying kif1a c.773C>T missense mutation.
    Xiaojing W; Yanyan M; Ruonan D; Xiaolin L; Haiyan Z; Jian M; Yi L; Wenjie S; Qiji L
    Stem Cell Res; 2020 Mar; 43():101727. PubMed ID: 32045731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of induced pluripotent stem cell line (ZZUi0016-A) from dermal fibroblasts of a normal human.
    Gao Y; Wang Y; Wang Z; Sun H; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Shi C; Xu Y; Song B
    Stem Cell Res; 2020 Mar; 43():101717. PubMed ID: 32007761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of induced pluripotent stem cell line (ZZUi0012-A) from a patient with Fahr's disease caused by a novel mutation in SLC20A2 gene.
    Zhang Q; Li Z; Sun H; Zhang S; Zhang J; Wang Y; Fang H; Xu Y
    Stem Cell Res; 2019 Mar; 35():101395. PubMed ID: 30776674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of induced pluripotent stem cell line (ZZUi0024-A) from a 51-year-old patient with APP gene mutation in Alzheimer' s disease.
    Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Wang Y; Xu Y
    Stem Cell Res; 2021 May; 53():102267. PubMed ID: 33652304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.
    Klebe S; Depienne C; Gerber S; Challe G; Anheim M; Charles P; Fedirko E; Lejeune E; Cottineau J; Brusco A; Dollfus H; Chinnery PF; Mancini C; Ferrer X; Sole G; Destée A; Mayer JM; Fontaine B; de Seze J; Clanet M; Ollagnon E; Busson P; Cazeneuve C; Stevanin G; Kaplan J; Rozet JM; Brice A; Durr A
    Brain; 2012 Oct; 135(Pt 10):2980-93. PubMed ID: 23065789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming of a human induced pluripotent stem cell line from one 48-year-old healthy male donor.
    Guo R; Mu W; Liu X; Zhang J; Liu B; Du X; He J; Ma J; Cui H
    Stem Cell Res; 2021 May; 53():102339. PubMed ID: 33892291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47).
    Teinert J; Behne R; D'Amore A; Wimmer M; Dwyer S; Chen T; Buttermore ED; Chen IP; Sahin M; Ebrahimi-Fakhari D
    Stem Cell Res; 2019 Oct; 40():101575. PubMed ID: 31525725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cell line(ZZUi006-A)from a patient with myotonic dystrophy type 1.
    Wang Y; Wang Z; Sun H; Shi C; Yang J; Liu Y; Liu H; Zhang S; Zhang L; Xu Y; Zhang J
    Stem Cell Res; 2018 Oct; 32():61-64. PubMed ID: 30216892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.